title: Society for Medicines Research: 40th anniversary symposium.
abstract: The recent symposium of the Society for Medicines Research (SMR), held on December 11, 2006, in Westminster, UK, celebrated the 40th anniversary of the formation of the SMR. The meeting began with an overview of future strategies for medicines research and its funding in Europe. This session was followed by the 2006 SMR Award lecture, which was given by Dr. Napoleone Ferrara of Genentech, for the development of the anti-vascular endothelial growth factor (VEGF) antibody bevacizumab for the treatment of cancer. The remainder of the meeting showcased the best of medicines research in the United Kingdom by highlighting a number of drug discovery success stories from several UK biotech companies, which covered the therapeutic areas of central nervous system, cancer and viral infection, along with regenerative medicine.
authors.affiliation: Society for Medicines Research (SMR) Committee, Thurmaston, Leicester, UK.
authors.forename: Alan M
authors.initials: AM
authors.lastname: Palmer
authors.forename: F Anne
authors.initials: FA
authors.lastname: Stephenson
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Williams
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001363:Awards and Prizes; D035843:Biomedical Research; D002491:Central Nervous System Agents / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000188:drug therapy; D005060:Europe; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D004364:Pharmaceutical Preparations; D014777:Virus Diseases / Q000188:drug therapy; D014945:Wound Healing
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D002491:Central Nervous System Agents; D004364:Pharmaceutical Preparations